SMAD7:乘坐纤维化限制路线及其他路线
Leonardo Martin1,2, Giulio Gabbiani3, Guido R Y De Meyer4,5
1Department of Pharmaceutical Sciences, Laboratory of Physiopharmacology, University of Antwerp, Universiteitsplein 1, 2610, Antwerp, Belgium. leonardo.martin@uantwerpen.be.
SMAD7通过向肌纤维细胞和巨细胞活动来抑制纤维化. 这种蛋白质在细胞疗法中表现有前途,用于修复器官和改善慢性疾病中的免疫反应.
科学领域:
- 纤维化研究纤维化.
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 纤维化,以过度的细胞外基质沉积为特征,驱动器官病理,如心脏和骨肌肉疾病.
- 肌纤维细胞激活,由转化生长因子-β (TGF-β) 介导,是纤维细胞重塑的核心.
- 作为TGF-β信号传递抑制剂的SMAD7,起到抗纤维素效应的作用,并调节免疫/组织重塑.
研究的目的:
- 审查SMAD7在心脏,骨肌肉和血管纤维化中的作用.
- 突出SMAD7在重编程纤维化和促进组织修复方面的治疗潜力.
- 强调SMAD7在调节免疫应对纤维化的功能.
主要方法:
- 对SMAD7在纤维化中的作用的现有文献的审查.
- 对SMAD7细胞特异性抗纤维菌作用的分析,特别是在肌纤维细胞中.
- 探索SMAD7在工程细胞疗法 (例如CAR-T细胞) 中的整合.
主要成果:
- 在肌纤维细胞中,SMAD7显示了细胞特异性抗纤维菌作用.
- 通过膜机制,SMAD7限制了巨驱动的纤维化.
- 在CAR-T细胞中SMAD7调节增强了再生结果和免疫弹性.
结论:
- SMAD7是治疗多个器官系统纤维化的有希望的治疗标.
- 向SMAD7可以重编程纤维化,促进组织修复和恢复器官功能.
- 在以纤维化和炎症为特征的慢性疾病的管理中,SMAD7起着至关重要的作用.
更多相关视频
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
06:35A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
Published on: December 22, 2020
相关概念视频
TGF - β Signaling Pathway
Introduction to Fibroblasts
Regulation of Angiogenesis and Blood Supply
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
